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a b s t r a c t
Translationally silenced mRNAs are recruited to two major classes of RNA granules in the cytoplasm,
processing bodies (PBs) and stress granules (SGs). We show that PBs accumulated after human
cytomegalovirus (HCMV) infection. PB assembly after HCMV infection was also detected in the presence
of the protein synthesis inhibitor, cycloheximide, but required active RNA synthesis. UV-inactivated
HCMV virions were sufﬁcient to induce PB accumulation in HFF cells treated with cycloheximide. Viral
IE1 RNA did not colocalize with PBs, and we could not detect an effect of PB accumulation on viral
growth. These results may indicate that HCMV inhibits the colocalization of IE1 mRNA with PBs,
preventing IE1 mRNA decay and translational inhibition.
& 2014 Elsevier Inc. All rights reserved.
Introduction
Although most individuals are infected by human cytomegalo-
virus (HCMV), the infection usually is asymptomatic. The virus is
reactivated under immunosuppressive conditions and may cause
pneumonitis, hepatitis, retinitis, and gastrointestinal diseases.
HCMV replicates productively in terminally differentiated cells
such as ﬁbroblasts, epithelial and endothelial cells, and in
monocyte-derived macrophages (Fish et al., 1995, 1996; Ibanez
et al., 1991; Lathey and Spector, 1991; Sinzger et al., 1995, 1996;
Taylor-Wiedeman et al., 1991). During productive infection, HCMV
genes are expressed in a temporal cascade, designated immediate
early (IE), early, and late. The major IE genes (MIE) UL123/122 (IE1/
IE2) play a critical role in subsequent viral gene expression and the
efﬁciency of viral replication (Isomura and Stinski, 2003; Isomura
et al., 2004, 2005; Meier et al., 2002; Meier and Pruessner, 2000;
Meier and Stinski, 1997). The early viral genes encode proteins
necessary for viral DNA replication (Pari and Anders, 1993).
Following viral DNA replication, delayed early and late viral genes,
which encode structural proteins in the virion, are expressed.
The regulation of mRNA biogenesis and decay is important for
maintaining host cell homeostasis during virus infection. mRNA decay
by host factors regulates viral protein levels, eliminates aberrant viral
mRNAs, and is consequently an essential host defense response to viral
infection (Coller and Parker, 2004). mRNA silencing and RNA decay are
closely linked via cross talk among proteins that regulate the initiation
of translation. eIF4A, eIF4E, eIF4G, and certain mRNPs counteract
silencing when bound to mRNPs and also regulate access to mRNA
by decapping complexes and deadenylases (Parker and Sheth, 2007).
mRNA decapping is a crucial step in general and specialized mRNA
decay (Parker and Song, 2004). Translationally silenced mRNPs may be
organized into two major classes of RNA granules in the cytoplasm,
processing bodies (P-bodies, PBs) and stress granules (SGs) (Reineke
and Lloyd, 2013). PBs contain translationally silenced mRNPs, which
are enriched for many proteins involved in mRNA decapping and
decay, such as Dcp1a, EDC4, and 4E-T (Eulalio et al., 2007). PBs have
been suggested to function in many pathways of mRNA decay and
repression of translation, ranging from nonsense-mediated decay and
miRNA-mediated decay to mRNA storage and miRNA-mediated
repression (Parker and Sheth, 2007; Seto et al., 2010). However,
whether mRNP assembly into PBs is important for translational
repression, decapping, or decay remains controversial. mRNA decap-
ping and mRNA translation are thought to be competing pathways.
PB-associated mRNPs are translationally repressed and can be
degraded or stored for subsequent translation (Ferraiuolo et al.,
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2005; Franks and Lykke-Andersen, 2008). Little is known about how
decapping enzymes become inactive in a PB when mRNPs are stored
for subsequent translation. It has been reported that interaction of 4E-
T with eIF4E is a priming event, inducing messenger ribonucleoprotein
rearrangement and transition from translation to decay (Ferraiuolo
et al., 2005).
Stress granules are dynamic structures that form quickly when
external stresses are applied to cells and global translation rates
decline, and disperse when translation conditions are restored. SGs
are thought to contain stalled 43S and 48S ribosomal preinitiation
complexes and have been suggested to serve as temporary repositories
for these complexes (Kedersha et al., 2002). It has been suggested that
there is a cytoplasmic mRNA cycle in which mRNPs move rapidly
between active polysomes and the silenced compartments of PBs and
SGs. This is supported by the observation that SGs and PBs are in
equilibrium with actively translating mRNPs, shown by experiments
involving chemical and genetic blockade of multiple steps in the
process of translation initiation and elongation (Dang et al., 2006;
Kedersha et al., 1999; Mokas et al., 2009). Furthermore, ﬂux between
the different RNA granules has been demonstrated by experiments
showing transient docking of SGs and PBs, and many proteins have
been detected in both compartments, such as Ago2, eIF4E, APOBEC3,
and others (Kedersha and Anderson, 2007; Kedersha et al., 2005).
Several other types of RNA granules have been described in Caenor-
habditis elegans and Drosophila neurons; these contain various levels of
proteins found uniquely in SGs or PBs (Buchan and Parker, 2009).
Thus, a continuum of RNA granules has been suggested to exist in
eukaryotic cells with degrees of similarity to SG and PBs.
In this report, we show for the ﬁrst time that PBs accumulate
dramatically during HCMV infection.
Results
HCMV infection caused accumulation of PBs
Viral and non-viral single-stranded RNAs can induce innate
immune responses (Brencicova and Diebold, 2013; Diebold et al.,
2004, 2006). It has been reported that SGs contain viral RNA and the
cytoplasmic RNA sensor RIG-I, which initiates antiviral interferon
responses in inﬂuenza A-infected cells (Onomoto et al., 2012; Yoo et
al., 2014). It is possible that PBs and/or SGs sense robust expression of
viral IE and cellular mRNAs to induce antiviral host defenses in HCMV-
infected cells. Because SGs are not formed during HCMV infection
(Isler et al., 2005), we sought to investigate whether PBs accumulate
during HCMV infection. Dcp1a and EDC4 have beenwell characterized
as markers for visualizing PBs and play a role in decapping and
enhancing decapping, respectively (Franks and Lykke-Andersen,
2008). HFF cells were infected with HCMV at an moi of 3 and then
stained with antibodies speciﬁc for Dcp1a and EDC4 at 6, 24, and
48 hpi. To detect PB formation, confocal images consisting of eight
1 mm slices along the z-axis were digitally merged. As shown in
Fig. 1A, PBs were detected by relocalization of Dcp1a and EDC4 to
discrete cytoplasmic puncta in the mock-infected cells, as described
previously (Parker and Sheth, 2007). The proportion of cells containing
more than three PB foci increased after HCMV infection (Fig. 1A–E).
The number of PB foci per cell also increased at 6, 24, and 48 hpi, and
larger PB foci accumulated to cover large areas of the entire cytoplasm
by 48 hpi (Fig. 1A–D and F). These results suggested that HCMV
infection induced the accumulation of PBs.
De novo protein synthesis was not required for PB accumulation
during HCMV infection.
Because Fig. 1 showed increased accumulation of PBs at 24 and
48 hpi, we sought to determine whether this accumulation was
associated with an increase in the abundance of PB proteins or simply
redistribution of existing PB proteins. HFF cells were infected with
HCMV at an moi of 3 and harvested before infection and at 24 hpi in
the presence or absence of the protein synthesis inhibitor, cyclohex-
imide, and at 6 and 48 hpi in the absence of cycloheximide for
Western blot analysis. As shown in Fig. 2A, IE1 and IE2 proteins were
detected at 6 hpi and increased at 24 and 48 hpi. In addition to the PB
markers, Dcp1a and EDC4, DDX6 and Lsm14A (also known as Rck/p54
and RAP55, respectively), which play a role in suppression of transla-
tion, 4E-T, which has been suggested to contribute to inhibition of cap-
dependent translation, and Lsm1, an mRNA decapping enzyme, were
tested (Ferraiuolo et al., 2005; Kufel et al., 2003; Yang et al., 2006).
HCMV infection induced a small increase in several of the factors in
the absence of cycloheximide (Fig. 2A).
Subsequently, to further determine whether protein synthesis is
required for the accumulation of PBs, HFF cells were infected with
HCMV at an moi of 3 or treated with 0.5 mM Arsenite for 30 min in
the presence or absence of cycloheximide, and stained with antibodies
speciﬁc for Dcp1a or Lsm14A, and EDC4, before infection and at 24 hpi.
Accumulation of PBs was induced as demonstrated by the relocaliza-
tion of Dcp1a or Lsm14A with EDC4 to discrete cytoplasmic puncta in
the cells treated with Arsenite (Fig. 2B). At 24 hpi, HCMV induced the
relocalization of Dcp1 or Lsm14 with EDC4 proteins in the absence or
presence of cycloheximide (Fig. 2B). Despite cycloheximide blocking de
novo protein synthesis, HCMV infection still induced accumulation of
PBs. PB formation was completely inhibited before infection in the
presence of cycloheximide (Fig. 2B) as described previously (Andrei
et al., 2005). Cycloheximide presumably trapped mRNAs in polysomes,
which depleted the cellular pool of ribosome-free mRNPs in the
uninfected cells (Franks and Lykke-Andersen, 2008). HFF cells infected
with HCMV in the presence of cycloheximide did not result in an
increase in Dcp1 and EDC4 protein (Fig. 2A); thus, these PB markers
assembled independent of de novo protein synthesis.
PBs have been implicated in miRNA-mediated post-transcrip-
tional gene silencing, and Ago2 is known to be a key mediator that
selectively recruits miRNAs and their target mRNAs to PBs (Holley-
Guthrie et al., 2005). To determine whether Ago2 is recruited to
PBs formed by HCMV infection, HFF cells were infected with
HCMV in the presence or absence of cycloheximide, and stained
with antibodies to EDC4 and Ago2 before infection and at 24 hpi.
In HCMV-infected cells, foci formation by Ago2 was not clearly
detected and Ago2 did not accumulate in PBs, as demonstrated by
colocalization with EDC4 foci, during HCMV infection in the
presence or absence of cycloheximide (Fig. 2C).
Inhibition of RNA transcription abrogated PB accumulation after
HCMV infection
To determine whether active transcription is required for the
accumulation of PBs induced by HCMV infection, HFF cells were
infected in the absence or presence of Actinomycin D (ActD), which
inhibits RNA synthesis, then immunostained with Lsm14A and EDC4.
As shown in Fig. 3A, inhibition of transcription for 24 h after HCMV
infection resulted in little to no PBs. ActD may have inhibited PB
accumulation altogether or induced PB dispersion after HCMV infec-
tion. The histogram in Fig. 3B shows the average number of PBs/cell
(Y axis). After treatment with ActD for 24 h, PBs had fallen to the level
before HCMV infection. These results clearly show that HCMV-induced
accumulation of PBs was dependent on active RNA synthesis.
UV-inactivated HCMV virions induced PB accumulation in HFF cells
To determine whether HCMV gene expression is essential for PB
accumulation, HFF cells were infected with HCMV, UV-inactivated
virions, or the culture supernatant after removal of virions at an
moi of 3. HFF cells were maintained in the absence or presence of
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cycloheximide, ﬁxed at 24 hpi, analyzed by FISH with an IE1 probe,
and then stained with the PB markers, Lsm14A and EDC4. To identify
each PB dot clearly, confocal images were not digitally merged. The
histogram in Fig. 4F shows the average number of PBs/cell (Y axis).
As shown in Fig. 4B, while UV inactivation of the virus inhibited
expression of IE1 mRNA, PB accumulation was still induced. Moreover,
UV inactivation decreased the numbers of PB foci in the absence of
cycloheximide (Fig. 4A, B and F). In contrast, UV inactivation did not
decrease the number of PB foci in infected HFF cells in the presence of
cycloheximide (Fig. 4C, D and F). When HCMV virions were removed
by ultracentrifugation, the culture supernatant itself did not induce PB
accumulation (Fig. 4E and F). From these results, we concluded that
UV-inactivated HCMV virions could induce PB accumulation, which
viral gene expression promoted during HCMV infection.
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Fig. 1. PB accumulation in HFF cells. HFF cells were mock infected (A) or infected with HCMV (B–D) at an moi of 3. The cells were then ﬁxed at 6 (B), 24 (C), and 48 (D) hours
post infection (hpi) and stained with mouse monoclonal antibody speciﬁc for Dcp1a and goat polyclonal antibody speciﬁc for EDC4, followed by staining with Alexa 568-
conjugated donkey anti-mouse IgG and Alexa 680-conjugated anti-goat secondary antibodies. Arrowheads indicate PBs that contain a detectable amount of Dcp1a and EDC4.
The histogram shows the ratio of the cells containing 0–2 or more than 3 (E), or the number of PBs/cell (F) counted using Dcp1a and EDC4 PB markers. (F) Left and right bars
represent the number of PBs with a diameter of less or more than 1 μm, respectively. nn indicates values of po0.01.
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Fig. 2. Various PB markers accumulated in the HFF cells infected with HCMV. (A) The amount of different PB markers increased during HCMV infection. HFF cells were infected with
HCMV at an moi of 3 in the absence or presence of 200 μM cycloheximide and then harvested at 0, 6, 24, and 48 hpi in the absence of cycloheximide and 0 and 24 hpi in the presence
of 200 μM cycloheximide. Immunoblot analysis was performed using an antibody against HCMV IE1 (IE72) and IE2 (IE86), DCP1a, EDC4, DDX6, 4E T, Lsm1, Lsm14A, or GAPDH at the
times indicated after HCMV infection. GAPDH served as a loading control. (B) Accumulation of various PB markers during HCMV infection. HFF cells were treated with 0.5 mMArsenite
for 30min or infected with HCMV at an moi of 3 in the absence or presence of 200 μM cycloheximide and ﬁxed at 0 and 24 hpi. The cells were stained with mouse monoclonal or
rabbit polyclonal antibody speciﬁc for Dcp1a or Lsm14A, respectively, and goat polyclonal antibody speciﬁc for EDC4, followed by staining with Alexa 568-conjugated donkey anti-
mouse or anti-rabbit IgG, respectively, and Alexa 680-conjugated anti-goat secondary antibodies. Histogram shows the ratio of PBs/cell counted using Dcp1a and EDC4 PBmarkers. Left
and right bars represent the number of PBs with a diameter of less or more than 1 μm, respectively. nn indicates values of po0.01. (C) HFF cells were infected with HCMV at anmoi of 3,
ﬁxed at 0 and 24 hpi, and then stained with mouse monoclonal antibody speciﬁc for Ago2 and goat polyclonal antibody speciﬁc for EDC4, followed by staining with Alexa 568-
conjugated donkey anti-mouse IgG and Alexa 680-conjugated anti-goat secondary antibodies.
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IE1 RNA did not colocalize with PBs in HCMV-infected cells
PB accumulation was induced by UV-inactivated HCMV virions,
and PBs increased during HCMV infection (see Fig. 1). Since active
RNA synthesis was required for PB accumulation in HCMV-infected
cells (see Fig. 3), it is possible that several viral cytoplasmic mRNAs
were also contained in the PBs. This would be consistent with the
function of PBs in RNA regulation (Parker and Sheth, 2007). We
hypothesize PBs that accumulate in response to HCMV infection are
the sites of RNA decay, which silences viral transcripts as a host
defense mechanism. To determine whether IE1 mRNA is associated
with PBs in HCMV infected cells, HFF cells were infected with HCMV
at an moi of 3 in the absence or presence of cycloheximide, ﬁxed at 1,
3, 6, and 24 or 24 hpi, respectively, analyzed by FISH with an IE1
probe, and immunostained. As shown in Fig. 5A–E, the number of
cytoplasmic IE1 mRNA and PBs increased dramatically at 3 and 6 hpi,
respectively. However, IE1 mRNA did not colocalize with PBs in
infected HFF cells in the absence of cycloheximide at 6 or 24 hpi
(Fig. 5C and D) or in the presence of cycloheximide at 24 hpi (Fig. 5E).
It should be noted that IE1 mRNA moved from the nucleus to the
cytoplasm at 3 hpi. EDC4 was mainly detected in the nucleus at 1 hpi,
but not 3 hpi, and the EDC4 in the nucleus did not colocalize with IE1
mRNA (Fig. 5A and B). These results may indicate HCMV inhibited
localization of IE1 mRNAs within PBs, preventing IE1 mRNA decay
and translational inhibition.
PB knockdown did not affect viral IE1 and IE2 steady-state RNA and
growth at a high multiplicity of infection
To determine whether PB knockdown affects viral IE steady-state
RNA and viral growth, PBs were disrupted by depleting essential PB
components, 4E-T, Lsm1, or Lsm14A, using speciﬁc siRNAs. HFF cells
were transfected with either a negative control siRNA or an siRNA
speciﬁc for the target PB component and, 48 h after transfection, the
cells were infected with HCMV at an moi of 3. Knocking down 4E-T,
Lsm1, or Lsm14A in HFF cells resulted in 99, 92, or 93% of PBs,
respectively at 24 hpi (Fig. 6B). To conﬁrm the knockdown effect of an
siRNA speciﬁc for 4E-T, Lsm1, and Lsm14A at the mRNA level and
determine whether an off-target effect occurred, cells were harvested
at 0, 3, 6, and 24 hpi and the mRNA expression levels of 4E-T, Lsm14A,
and Lsm1 were quantitated. Transfection of an siRNA speciﬁc for the
PB components did not affect the expression levels of HPRT and 18S
RNAs throughout infection (data not shown). Therefore, HPRT mRNA
was used to normalize RNAs for quantitative real-time RT-PCR. When
the siRNA speciﬁc for 4E-T, Lsm1, or Lsm14A was transfected, the
concentration of the corresponding mRNAwas signiﬁcantly decreased
throughout infection (Fig. 6A). The expression levels of 4E-T and Lsm1
or Lsm14A were signiﬁcantly decreased at 24 hpi in cells transfected
with the siRNA for Lsm14A or Lsm1, respectively (Fig. 6A). There was
also a signiﬁcant decrease in expression levels of Lsm1 in cells
transfected with siRNA for Lsm14A at 3 hpi (Fig. 6A). These were
due to an off-target effect of the siRNA. The amount of IE1 and IE2
mRNA reached a maximum at 6 and 3 hpi, respectively (Fig. 6A).
When an siRNA speciﬁc for 4E-T, Lsm1, or Lsm14A was transfected
before HCMV infection, IE1 and IE2 mRNA levels were not signiﬁ-
cantly decreased at any time point examined during HCMV infection
relative to an siNeg control (Fig. 6A). From these results, we
concluded that the PBs induced by HCMV infection did not trigger
mRNA decay of the IE1 and IE2 transcripts.
To determine the effect of PB knockdown on viral DNA
replication and growth, PBs were disrupted by depleting the
essential PB components, 4E-T or Lsm1, using speciﬁc siRNAs.
HFF cells were transfected with either a negative control siRNA
(siNeg) or an siRNA speciﬁc for 4E-T or Lsm1 and, 48 h after
transfection, were infected with HCMV at an moi of 3, harvested at
the indicated dpi, stained with PB markers, and subjected to viral
DNA replication and growth assays. Knocking down 4E-T or Lsm1
in HFF cells did not affect viral DNA replication and growth at a
high moi infection (Fig. 7A and B). Knockdown by siRNA was not
sufﬁcient to determine the role of PBs in viral DNA replication and
growth at a low moi infection (data not shown).
Fig. 3. PB accumulation in HFF cells treated with or without Actinomycin D during
HCMV infection. (A) HFF cells were infected with HCMV at an moi of 3 in the
absence or presence of 200 μM Actinomycin D, then ﬁxed before infection and at 24
hpi, and stained with rabbit polyclonal antibody speciﬁc for Lsm14A and goat
polyclonal antibody speciﬁc for EDC4, followed by staining with Alexa 568-
conjugated donkey anti-rabbit IgG and Alexa 680-conjugated anti-goat secondary
antibodies. (B) Histogram shows the average number of PBs/cell (Y axis), counted
using Lsm14A and EDC4 PB markers. Thirty cells were selected from multiple ﬁelds
of view and the numbers of Lsm14A and EDC4 double-positive granules per cell
were counted for quantiﬁcation. Left and right bars represent the number of PBs
with a diameter of less or more than 1 μm, respectively. nn indicates values of
po0.01. Data shown are the mean of three experiments, and the error bars
indicate SD.
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Fig. 4. PB accumulation in HFF cells infected with HCMV or UV-inactivated HCMV. HFF cells were infected with HCMV (A or C), or UV-inactivated virions (B and D), or the
culture ﬂuid after removal of HCMV virions (E) at an moi of 3. HFF cells were maintained in the absence (A and B) or presence (C and D) of cycloheximide. Cells were analyzed
for IE1 RNA by FISH and then stained with rabbit polyclonal antibody speciﬁc for Lsm14A and goat polyclonal antibody speciﬁc for EDC4, followed by staining with Alexa
488-conjugated donkey anti-rabbit and Alexa 680-conjugated anti-goat IgG secondary antibodies. (F) Histogram showing the number of PBs/cell. Thirty cells were selected
from multiple ﬁelds of view, and the number of Lsm14A and EDC4 double-positive PBs were counted. Data are averages of merged dots determined by counting three times
independently, and the error bars indicate SD.
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Fig. 5. Cytoplasmic distributions of IE1 mRNA and PB markers, Lsm14A and EDC4. HFF cells were infected with HCMV at an moi of 3 and ﬁxed at 1 (A), 3 (B), 6 (C), and 24
(D) hpi. Infected HFF cells were also maintained in the presence of cycloheximide and ﬁxed at 24 hpi (E). These cells were analyzed with IE1 probe by FISH and then stained
with rabbit polyclonal antibody speciﬁc for Lsm14A and goat polyclonal antibody speciﬁc for EDC4, followed by staining with Alexa 488-conjugated donkey anti-rabbit IgG
and Alexa 680-conjugated anti-goat secondary antibodies.
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Discussion
The mechanisms by which PB formation, maintenance, and
disassembly are controlled remain poorly understood. The detailed
composition of cellular factors involved in PB dynamics also is not
known. PBs are highly dynamic structures, and their assembly is
tightly linked to the availability of free cytoplasmic mRNAs. During
HCMV infection, PB markers increased slightly in abundance and
were detected diffusely in the cytoplasm. Here, we show that PB
assembly after HCMV infection did not require de novo protein
synthesis, but did require active RNA synthesis. Moreover, the data
indicates that PB assembly after HCMV infection required cellular
RNA synthesis, not viral RNA synthesis, as UV-inactivated HCMV
virions were sufﬁcient in inducing PBs. Transient transfection of an
Fig. 6. Knockdown effect of PB components on viral gene expression in HCMV-infected cells. HFF cells were transfected with siRNAs targeting 4E-T, Lsm1, and LSM14A, or
with a non-targeting siRNA (siNeg), and, 2 days after transfection, infected with HCMV at an moi of 3. (A) Effect of siRNAs speciﬁc for the PB components, 4E-T, Lsm1, and
Lsm14A on mRNA expression of the corresponding gene and viral mRNA expression. The transfected and infected cells were harvested at 0, 3, 6, and 24 hpi. Total RNA was
isolated and subjected to quantitative real-time RT-PCR analysis to detect the gene transcripts indicated on the Y axis. RNAs were normalized to HPRT RNA and values were
calculated relative to siNeg at 0 (upper panel) or 3 (lower panel) hpi. Data are averages of three independent experiments. Statistical analyses were done using the t-test. RNA
expression levels compared to siNeg were assessed for statistical signiﬁcance. n indicates values of po0.05. nn indicates values of po0.01. (B) The transfected and infected
cells were ﬁxed at 24 hpi and stained with rabbit polyclonal antibody speciﬁc for Lsm14A and goat polyclonal antibody speciﬁc for EDC4, followed by staining with Alexa
568-conjugated donkey anti-rabbit IgG and Alexa 680-conjugated anti-goat secondary antibodies. Histogram showing the effect of siRNAs targeting 4E-T, Lsm1, and LSM14A,
or with a non-targeting siRNA (siNeg) on the ratio of the PB number/cell. Thirty cells were selected frommultiple ﬁelds of view, and the number of Lsm14A and EDC4 double-
positive PBs were counted. Data are averages of merged dots determined by counting three times independently, and the error bars indicate SD.
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IE1 expression plasmid did not induce PBs in HFF cells (data not
shown). These results suggest cytoplasmic mRNAs and PB factors
assembled into PBs in a translation-independent manner in
HCMV-infected cells. It is likely that several viral and cellular
cytoplasmic mRNAs and RNA-binding proteins, which increased
and formed a complex during HCMV infection, were assembled
into PBs. We are currently investigating whether HCMV infection
results in the inclusion or exclusion of speciﬁc cellular and viral
RNAs in PBs.
It has been reported recently from Ago2 knockdown studies
that Ago2 is required for miR-122-dependent HCV RNA replication
and translation (Wilson et al., 2011). The HCMV genome also
encodes at least 14 microRNAs (Fannin Rider et al., 2008), some of
which are known to be functional (Gray et al., 2007, 2010).
However, because PBs formed during HCMV infection did not
contain Ago2, it seems unlikely that these function as an assembly
site for HCMV microRNAs.
PBs are known to be active in the degradation of bulk mRNA,
including nonsense-mediated mRNA decay (Franks and Lykke-
Andersen, 2008; Sheth and Parker, 2006). In HCMV-infected HFF
cells, while IE1 mRNA did not colocalize with PBs, we cannot rule
out the possibility that IE1 mRNAs were surrounded by multiple
RNP proteins which disturbed hybridization with the IE1 probe.
PBs and IE1 mRNA moved independently in the cytoplasm. We
speculate that these results suggest IE1 mRNA evasion from PB-
mediated RNA silencing. HCMV might prevent colocalization of IE1
mRNAwith PBs. Further studies are required to determine how IE1
RNAs evade PBs in HCMV-infected cells.
We could not detect the effect of PBs on viral DNA replication
and growth at a high moi in HFF cells using siRNA speciﬁc for PB
components. Knockdown by siRNA was not perfect, and the
knockdown effect was not sufﬁcient to assess the role of PBs at a
low moi. Therefore, to deﬁne whether PBs have an effect on HCMV
DNA replication and growth requires a complete knockout of PB
components in HFF cells.
Materials and methods
Cells and virus
Primary human foreskin ﬁbroblast (HFF) cells were propagated
and maintained at 37 1C in 5% CO2 in Eagle's medium (Sigma-
Aldrich, St. Louis, MO) supplemented with 10% FBS (PAA labora-
tories, Pasching, Austria), penicillin (100 U/ml), and streptomycin
(100 μg/ml). To obtain the Towne strain of HCMV containing green
ﬂuorescent protein (GFP), the culture ﬂuid from HFF cells trans-
fected with the Towne BAC clone (kindly provided by Dr. Fenyong
Liu, University of California, Berkeley) was collected after 7 days of
100% cytopathic effect and propagated as described previously
(Isomura et al., 2004, 2005; Stinski, 1977). UV inactivation of
virions in the culture ﬂuid from the HCMV-infected cells was
performed in a UV Stratalinker 2400 (StrataGene) for 4 min at
9.9105 μJ for 4 min. To remove virions from the culture ﬂuid,
ultracentrifugation was at 54,000 rpm for 1 h in SW60 Ti rotor, UV
inactivation and removal of virions in the culture ﬂuid were
conﬁrmed by monitoring expression of the immediate-early (IE)
gene products (IE1 and IE2) in infected HFF cells as previously
described (Lopper and Compton, 2004). The UV treatment
described was sufﬁcient to completely abolish IE gene expression.
UV inactivation of virions was conﬁrmed by monitoring expression
of the immediate-early (IE) gene products (IE1 and IE2) in infected
HFF cells as previously described (Lopper and Compton, 2004).
Antibodies
The antibodies against HCMV IE1 (IE72) and IE2 (IE86) and
UL44 proteins were described previously (Isomura et al., 2004).
Goat polyclonal antibody against EDC4 (sc-137444), and rabbit
polyclonal antibody against Lsm1 (sc-67365) were from Santa Cruz
Biotechnology, (Santa Cruz, CA) and mouse monoclonal antibody
against Dcp1a, clone 3G4 (Cat# H00055802-M6), was from
Abnova (Taipei, Taiwan). Rabbit polyclonal antibody against
DDX6 (Cat# 9407) was from Cell Signaling (Beverly, MA) and
rabbit polyclonal antibody against Lsm14A (Cat# ABE37) was from
Millipore (Billerica, MA). Mouse monoclonal antibodies against
Ago2 (Cat# 011–22033) and GAPDH (Cat# MAB374) were from
Wako Pure Chemical Industries Ltd. (Osaka, Japan), and Chemicon
(Temecula, CA), respectively. The secondary antibody conjugated
with HRP-, or 488-, 594-, or 680-Alexa Fluor was purchased from
Dako (Japan Inc., Tokyo, Japan), or Molecular Probes (Invitrogen
Life Technologies, Carlsbad, CA).
Immunoblot analysis
Cells were harvested at the times indicated post infection,
washed with PBS and then lysed with RIPA buffer (50 mM Tris–
HCl, pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate,
0.1% SDS) supplemented with a Complete protease inhibitor cock-
tail tablet (Roche, Mannheim, Germany). The lysates were rotated
for 40 min at 4 1C and centrifuged at 10,000 g for 10 min. The
clariﬁed cell extracts were then assayed for protein concentration
using the DC protein assay reagent (BioRad, Hercules, CA, Cat#
500-0116JA). Ten micrograms of the proteins were loaded onto
SDS-PAGE (acrylamide concentration 10%). The electrophoretically
separated proteins were transferred to PVDF membranes, blocked
with Blocking One (Nacalai tesque, Inc., Kyoto, Japan) and probed
with the antibodies indicated diluted with 20x Blocking One in
0.1% Tween 20 with PBS (PBS-T) at 4 1C overnight. After washing
with PBS-T, the blots were probed with HRP-conjugated secondary
antibodies for 1 h at R/T. After washing, target proteins were
detected with Supersignal West femto Chemiluminescent Sub-
strate (Thermo Scientiﬁc Waltham, MA) and visualized using a
Fig. 7. Effect of PB knockdown on viral DNA replication and growth. HFF cells were
transfected with either a non-targeting siRNA (siNeg) or siRNAs speciﬁc for PB
components, 4E-T or Lsm1, and, 48 h after transfection, the cells were infected with
HCMV at an moi of 3, harvested at the indicated dpi, and subjected to viral DNA
replication (A) and growth (B) assays.
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ImageQuant LAS 4000 (GE Healthcare Life Sciences, Buckingham-
shire, UK). Quantiﬁcation of the proteins was performed using
ImageQuant TL software (GE Healthcare Life Sciences) according to
the manufacturer's instructions.
Immunoﬂuorescence analysis
Conﬂuent HFF cells on coverslips in 24-well plates were
infected with HCMV at an moi of 3. At the times indicated after
infection, cells were washed twice with PBS, ﬁxed with 4%
paraformaldehyde for 15 min at room temperature (R/T), treated
with PBS containing 0.1% Triton-X 100, and incubated with
blocking buffer containing 3% bovine serum albumin for 1 h. After
blocking, cells were stained with the primary antibody indicated
for 1 h at R/T, washed three times with washing buffer (0.1% BSA,
0.05% azide in PBS), and stained with the indicated Alexa ﬂuor-
conjugated secondary antibodies for 1 h. After washing with wash
buffer three times, cells were mounted in ProLong Gold antifade
reagent with 40,6-diamidino-2-phenylindole (DAPI) (Molecular
Probes). Image acquisition was performed using a FV1000 micro-
scope (Olympus, Tokyo, Japan) equipped with a 401.4 NA oil-
immersion objective lens. To detect PB formation, confocal images
consisting of 1 mmwere obtained, and eight slices along the z-axis
were digitally merged. Thirty cells were selected from multiple
ﬁelds of view and the numbers of Dcp1a (Figs. 1 and 2B), or
Lsm14A (Figs. 3B and 4) and EDC4 double-positive granules per
cell were counted for quantiﬁcation. Data are averages of the ratio
of the merged dots determined by counting 100 dots indepen-
dently three times. Statistical analyses were performed with Two-
way ANOVA using Prism 4 software. To induce PBs, cells were
treated with 0.5 mM sodium Arsenite (Sigma-Aldrich) for 30 min.
To inhibit RNA or protein synthesis, Actinomycin D (Sigma-
Aldrich) or Cycloheximide (Sigma-Aldrich) was added to the
medium at ﬁnal concentrations of 5 μg/ml or 200 μg/ml, respec-
tively, 30 min before infection and maintained throughout
infection.
Fluorescence in situ hybridization (FISH) assay
HCMV IE1 RNA was detected using the QuantiGene View RNA
ISH cell assay kit (Affymetrix, Santa Clara, CA) and IE1 probe
(Affymetrix) that can hybridize to exon 4 of the HCMV genome.
Cells were ﬁxed in 4% paraformaldehyde for 30 min at R/T,
permeabilized, treated with protease, and hybridized according
to the manufacturer's instructions. After hybridization, immuno-
ﬂuorescence analysis was performed with antibodies against
Lsm14A or Lsm1, and EDC4 to detect PBs as described above,
followed by staining with Alexa 488-conjugated donkey anti-
rabbit IgG and Alexa 680-conjugated anti-goat secondary
antibodies.
siRNA transfection
HFF were transfected with siRNAs (30 pmol/106 cells) using a Cell
Line Nucleofector kit V (Amaxa Biosystems, Cologne, Germany, VCA-
1003), following the manufacturer's protocol. SMARTpool siRNA
against, 4E-T (M-013237-00-0005), Lsm1 (M-005124-01-0005), and
Lsm14A (M-013920-00-0005), and non-targeting siRNA pool #2 (D-
001206-14-05) were purchased from Dharmacon (Chicago, IL). After
transfection using a Cell Line Nucleofector kit V, the cells were seeded
at an initial density of 106 cells per well in 12-well plates and
incubated for 48 h before HCMV infection.
RNA extraction and real-time quantitative PCR (qPCR)
Total RNA was extracted from infected cells using the Trizol
reagent (Invitrogen Life Technologies) and DNase treatment was
performed as described previously (Isomura et al., 2011). For cDNA
synthesis, 800 ng of total RNA was reverse-transcribed using
Superscript III reverse transcriptase (Invitrogen Life Technologies)
with random hexamers. 0.5 ng of cDNA aliquots from each sample
were subjected to quantitative real-time PCR analysis using the
Mx3000P Real-Time qPCR system (Agilent Technologies, Santa
Clara, CA). Each 20 μl qPCR reaction contained 0.25 μM forward
primer, 0.25 μM reverse primer, and 1x Thunderbird SYBR qPCR
mix (Toyobo Co., Ltd., Osaka, Japan). The forward and reverse
primer sets are as follows. 50-CAACGAGAACCCCGAGAAA-30 (for-
ward) and 50-CCATGTCCACTCGAACCTTAA-30 (reverse) for IE1
(spanning exon 3 to exon 4), 50-ACAAGTGACCGAGGATTGCAA-30
(forward) and 50-GCCTGGGCGAGGATGTC-30 (reverse) for IE2
(spanning exon 3 to exon 5), 50-TGACCTTGATTTATTTTGCATACC-30
(forward) and 50-GGAGCAAGACGTTCAGTCCT-30 (reverse) for HPRT,
50-TTTCCAGCCTTTCTGCAAAT-30 (forward) and 50-CCTTCAAGCCC-
TTCAGACCT-30 (reverse) for 4E-T, 50-GGTCAGAGGAGAAAATG-
TGGTC-30 (forward) and 50-CCACCCTTTGTTCTTCTAGAATTT-30
(reverse) for Lsm1, 50-CAGCTGTTGGGAGAAGGAGT-30 (forward)
and 50-TCTGGCCTTGAAACTTTGTGT-30 (reverse) for Lsm14A. The
PCR reactions were performed in 96-well cluster plates at 95 1C for
3 min, followed by 40 cycles of 95 1C for 15 s, 60 1C for 30 s, and
72 1C for 30 s with melting curve analysis (95 1C for 1 min, 60 1C
for 30 s, and 95 1C for 30 s). A standard curve was constructed
using serial dilutions of cDNA from an arbitrary RNA set to 1.0, and
a relative amount of each gene expression was calculated based on
the standard curve using MxPro Software version 4.10. RNAs were
normalized to HPRT RNA. Statistical analyses were done using the
t-test with a software program, Prism4. The mean RNA expression
levels from experimental samples were assessed for statistical
difference from RNA isolated from cells transfected with siNeg.
n indicates values of po0.05. nn indicates values of po0.01.
Viral DNA replication and growth assays
HFF cells were transfected with either negative control siRNA
or siRNA against 4E-T or Lsm1, as described above. Forty-eight
hours after transfection, the cells were infected with HCMV at an
moi of 3 and supernatants at 4, 5, and 7 days post infection (dpi)
and cell lysates at 4 h and 2, 3, and 4 dpi of the infected cells were
collected for further analysis. To prepare cell lysates for DNA
replication assays, cells were suspended in PCR lysis buffer
(50 mM Tris–HCl, pH 8.0, 10 mM EDTA, 1% SDS, and 20 μg/ml
RNase A) containing 50 μg/ml proteinase K. After incubation at
55 1C for 100 min, the proteinase K was inactivated at 95 1C for
10 min. The input and replicated viral DNAs were detected by real-
time PCR using HCMV gB primers, as described previously
(Isomura et al., 2004). Real-time PCR with 18S rRNA gene primers
was performed to serve as an internal control for input DNA. Data
are averages of three independent experiments. The virus titers
of the supernatants were determined by the 50% tissue culture
infectious dose (TCID50) assay on HFF cells using GFP ﬂuorescent
foci in monolayers of HFF cells infected with serially diluted
supernatants and quadruplicate infections. TCID50 was calculated
using the method of Reed and Muench.
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